Monkey pox: EU purchases over 100,000 doses of vaccine
Monkeypox has been detected in 19 Member States, Norway and Iceland. This vaccine was authorized in 2013 against smallpox in adults.
I subscribe for 1€ the 1st month
The European Commission and the Danish laboratory Bavarian Nordic announced on Tuesday the conclusion of a contract for the purchase of more than 100,000 doses of vaccines against monkeypox, detected in 19 Member States as well as in Norway and Iceland . The agreement covers the supply of 109,090 doses of vaccines on behalf of European countries, the Commission said in a press release. It is inspired by the group purchases of anti-Covid vaccines, but concerns much smaller quantities. Marketed under the name Imvanex in Europe, Jynneos in the United States and Imvamune in Canada, it is a 3rd generation vaccine (non-replicating live vaccine, i.e. not replicating not in the human body) authorized in Europe since 2013 and indicated against smallpox in adults.
The European medicines regulator (EMA) announced in early June that it had started discussions with Bavarian Nordic to possibly extend its use against monkeypox. Some 900 cases have been reported since May 18 in European countries, according to the Commission. The amount of the contract was not disclosed. This disease is most often benign, but its spread outside endemic areas, mainly in Europe, remains a source of concern. It first results in a high fever and quickly evolves into a rash, with the formation of scabs.
First delivery at the end of June
The European Center for Disease Control and Prevention has recommended early post-exposure vaccination to prevent the disease or make its development less serious, recalls Brussels. Purchased on behalf of the new Hera health authority (created in the wake of the Covid-19 pandemic), the vaccines will be made available to the Twenty-Seven as well as to Norway and Iceland, with first deliveries of 'by the end of June for the priority countries, then deliveries between July and mid-August, specifies the Commission.
“This is the first time that we have used the European budget , through the EU4Health programme, to respond to a health emergency […] This is extremely tangible proof of a collective reaction made possible for the Health Union”, which began to materialize with the Covid-19 pandemic. 19, welcomed the European Commissioner for Health, Stella Kyriakides. According to the WHO, as of June 8, the number of confirmed cases of this disease stood at nearly 1,300 worldwide in non-endemic countries. A less dangerous cousin of smallpox, eradicated some 40 years ago, monkeypox is endemic in 11 West and Central African countries.